CXCR4 and experimental autoimmune encephalomyelitis: These synthetic receptor antagonists inhibited EAE by interfering with the action of CXCR3 and CXCR4 in a mouse model of multiple sclerosis called experimental autoimmune encephalomyelitis (EAE).